clioquinol has been researched along with Sleep Initiation and Maintenance Disorders in 1 studies
Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prevalence of subjective insomnia (6 ≤ Athens Insomnia Scale score) was 89." | 1.51 | Sleep problems in subacute myelo-optico neuropathy (SMON). ( Abe, K; Hishikawa, N; Ohta, Y; Sakai, K; Sato, K; Takemoto, M; Yamashita, T, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hishikawa, N | 1 |
| Takemoto, M | 1 |
| Sato, K | 1 |
| Yamashita, T | 1 |
| Ohta, Y | 1 |
| Sakai, K | 1 |
| Abe, K | 1 |
1 other study available for clioquinol and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
Sleep problems in subacute myelo-optico neuropathy (SMON).
Topics: Aged; Aged, 80 and over; Clioquinol; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Per | 2019 |